Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson's disease

The Pharmacogenomics Journal
Y Gilgun-SherkiD Offen

Abstract

Idiopathic Parkinson's disease (IPD) is a progressive neurodegenerative disorder for which no restorative or neuroprotective therapy is available. Interest has recently been directed to association studies on polymorphisms of various genes, mainly those related to dopamine metabolism and transport, and their effect on response to PD, which includes primarily levodopa and dopaminomimetics. Approximately 15-20% of patients with PD do not respond to levodopa, and the majority of those who do respond develop adverse fluctuations in motor response, primarily levodopa-induced dyskinesias. This review summarizes the influence of polymorphisms in various genes on the relative risk of IPD and on levodopa efficacy. It focuses on the importance of well-designed polymorphism studies that include large samples of patients with IPD and tightly matched controls and use identical methodologies. Valid data on such polymorphisms might increase the efficacy of levodopa, decrease its side effects, and reduce the occurrence of levodopa-induced dyskinesias. They might also provide a novel diagnostic tool for PD.

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Oct 2, 1991·JAMA : the Journal of the American Medical Association·D E ComingsB W Kovacs
Sep 1, 1991·Human Genetics·M Le ConiatR Berger
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D K GrandyA C Server
Apr 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·J G NuttT L Trotman
May 1, 1989·Annals of Neurology·M M MouradianT N Chase
Aug 1, 1980·Clinical Pharmacology and Therapeutics·D K ReillyD Van Dyke
Jul 14, 1995·Neuroscience Letters·S E PodusloJ Schwankhaus
May 1, 1993·Canadian Journal of Physiology and Pharmacology·M WuG J Mogenson
Mar 1, 1995·Annals of Neurology·S L HoA C Williams
Nov 1, 1994·Environmental Health Perspectives·A K DalyJ R Idle
Feb 1, 1995·Brain Research. Molecular Brain Research·S IkebeT Ozawa
Dec 15, 1994·American Journal of Medical Genetics·S NankoH Kazamatsuri
Feb 1, 1995·Annals of Neurology·W C KollerA Karst
Jun 18, 1994·Lancet·R BenjaminC M Morris
May 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·G S HotamisligilJ Sullivan
May 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·V Planté-BordeneuveA E Harding
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·R MarconiY Agid
Apr 1, 1993·Annals of Neurology·J H KurthJ D Schwankhaus
Jul 16, 1996·Biochemical and Biophysical Research Communications·R EgenspergerM B Graeber
Apr 15, 1996·Journal of Neuroscience Research·S KöselM B Graeber
Jan 22, 1996·American Journal of Medical Genetics·M D BrownD C Wallace
Dec 1, 1995·Journal of the Neurological Sciences·D IbarretaM S Ayuso
Dec 1, 1995·Acta Neurologica Scandinavica·M A HelyM A Adena
Jan 1, 1996·Methods in Enzymology·A K DalyJ R Idle
Apr 1, 1996·Brain : a Journal of Neurology·P K MorrishD J Brooks
Jan 1, 1996·Journal of Neural Transmission. Supplementum·C M MorrisE K Perry
Aug 1, 1996·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·P J BlanchetP J Bédard
Feb 16, 1996·Neuroscience Letters·S HelisalmiH Soininen
Jan 1, 1996·Journal of Neural Transmission·F TakakuboI Kondo
Oct 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·A S WhiteheadY Ben-Shlomo

❮ Previous
Next ❯

Citations

Nov 19, 2008·Journal of Neurology·Francesca Del Sorbo, Alberto Albanese
Dec 27, 2007·Acta Pharmacologica Sinica·Serena RosnerAvi Orr-Urtreger
Jun 16, 2012·Parkinson's Disease·Nicola TambascoPaolo Calabresi
Jul 30, 2014·Journal of the Neurological Sciences·Yong-Xin SunJiu-Han Zhao
Sep 17, 2014·The International Journal of Neuroscience·Eleonora DžoljićVladimir Kostić
Dec 7, 2007·Expert Review of Neurotherapeutics·Mario Di NapoliDavid A Stewart
Dec 19, 2006·Neuroscience Research·Monika BialeckaMarek Drozdzik
Jan 26, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Judith A StrongLei Yu
Apr 9, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian PausUllrich Wüllner
Jul 13, 2005·Trends in Pharmacological Sciences·Gurutz Linazasoro
Oct 26, 2018·The Journal of Pharmacy and Pharmacology·Erinaldo Ubirajara Damasceno Dos SantosPaulo Roberto E de Souza
Nov 1, 2006·Journal of Health Communication·Elizabeth A SmithRuth E Malone
May 24, 2019·Neuromolecular Medicine·Erinaldo Ubirajara Damasceno Dos SantosPaulo Roberto Eleutério de Souza
Feb 10, 2021·Parkinsonism & Related Disorders·Marika FallaGiovanni Fabbrini
May 7, 2021·Journal of Experimental Pharmacology·Andrea Fabbrini, Andrea Guerra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved